Creating a Pharmacotherapy Collaborative Practice Network to Manage Medications for Children and Youth: A Population

Richard H Parrish II1,2, Danielle Casher3, Johannes van den Anker4,5,6

  • 1Department of Pharmacy Services, St. Christopher's Hospital for Children ⁻ American Academic Health System, 160 East Erie Avenue, Philadelphia, PA 19134, USA. Richard.Parrish@AmericanAcademic.com.

Insights

Clinical pharmacists in Patient-Centered Medical Homes can improve care for children with special health care needs through comprehensive medication management. This integration enhances outcomes, family experience, and cost-effectiveness.

Area of Science:

  • Pediatric Healthcare
  • Clinical Pharmacy Practice
  • Health Services Research

Background:

  • Children with special health care needs (CSHCN) incur higher healthcare costs and morbidity.
  • Current healthcare models may not fully address the complex medication needs of CSHCN.

Purpose of the Study:

  • To outline a framework for integrating clinical pharmacists into Patient-Centered Medical Homes (PCMH) for comprehensive medication management (CMM) of CSHCN.
  • To propose models and infrastructure for collaborative practice agreements (CPAs) between pharmacists and pediatricians.

Main Methods:

  • The paper applies findings from the CMM in Primary Care grant.
  • It outlines the establishment of collaborative practices, proposes organizational models, and details EHR requirements.
  • Focuses on consistent CMM documentation for CSHCN.

Main Results:

  • Provides potential network infrastructures for collaborative practice targeting CSHCN.
  • Defines common language and terminology for CMM.
  • Offers clinical pharmacist workforce estimates.

Conclusions:

  • Embedding clinical pharmacists in PCMHs for CMM can improve outcomes for CSHCN.
  • This integration can enhance family experience and reduce healthcare costs.
  • The paper provides a practical guide for implementing CMM services for CSHCN.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
887
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
235
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
201
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
342
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
256
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
431